Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy

Blood (2022) 139 (14): 2156–2172.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals